Watermark Asset Management’s Pfizer PFE Stock Holding History

Watermark Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$63K	Buy	1,523 +155	+11%	+$6.43K	0.03%	77
2018 Q3	$57K	Buy	1,368 +8	+0.6%	+$308	0.02%	89
2018 Q2	$47K	Buy	1,360 +145	+12%	+$4.96K	0.02%	92
2018 Q1	$41K	Buy	1,215 +9	+0.7%	+$309	0.02%	104
2017 Q4	$41K	Buy	1,206 +9	+0.8%	+$307	0.02%	105
2017 Q3	$41K	Buy	1,197 +9	+0.8%	+$289	0.02%	101
2017 Q2	$38K	Buy	1,188 +11	+0.9%	+$347	0.02%	107
2017 Q1	$38K	Buy	+1,177	New	+$37.1K	0.02%	102

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Watermark Asset Management's PFE Position: Q4 2018 in Review

Watermark Asset Management increased its Pfizer (PFE) stake by 11% in Q4 2018, buying an estimated $6.43K and bringing the position to 1,523 shares worth $63K. The position accounts for 0.03% of the portfolio, ranked #77.

Watermark Asset Management first reported a position in PFE in Q1 2017 and has held it in 8 quarters since. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Watermark Asset Management held 1,523 shares of Pfizer worth $63K as of Q4 2018.
Watermark Asset Management bought 155 Pfizer shares in Q4 2018, an estimated $6.43K.
Pfizer made up 0.03% of Watermark Asset Management's portfolio in Q4 2018, its #77 holding.
Watermark Asset Management first reported a position in Pfizer in Q1 2017 and has held it in 8 quarters since.
2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Watermark Asset Management's 13F filing for Q4 2018, filed 14 Jan 2019.